GENELUX Corp

Pharmaceutical company · Westlake Village, California, United States · Nasdaq: GNLX

GENELUX Corp is a pharmaceutical company headquartered in Westlake Village, California, United States. Its shares trade on Nasdaq under the ticker GNLX. It has reported private securities offerings to the US SEC, most recently $5.5 million sold in a notice filed in 2023.

Profile compiled from public records. Is this your company? Request a correction or update

GENELUX at a glance

Typepharmaceutical company

HeadquartersWestlake Village, California, United States

Stock listingNasdaq: GNLX

SEC industryPharmaceutical Preparations

SEC CIK1231457

What does GENELUX do?

Private fundraising reported to the SEC

5 Form D notices; the most recent reported $5.5 million sold (2023).

Frequently asked questions about GENELUX

Where is GENELUX headquartered?

GENELUX Corp is headquartered in Westlake Village, California, United States.

What does GENELUX do?

GENELUX Corp is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.

Is GENELUX a public company?

Yes. GENELUX Corp trades on Nasdaq under the ticker GNLX.

Similar companies

Arcutis Biotherapeutics, Inc.Westlake Village, California, United States
Sienna Biopharmaceuticals, Inc.Westlake Village, California, United States
Turn Therapeutics Inc.Westlake Village, California, United States
Rebus Holdings, Inc.Westlake Village, California, United States
EOM Pharmaceutical Holdings, Inc.Westlake Village, California, United States
AbbVie Inc.North Chicago, Illinois, United States
Savara IncAustin, Texas, United States
Crinetics Pharmaceuticals, Inc.San Diego, California, United States

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-24. Data licences